The Bray family had always prided themselves on a positive outlook in life.
And in 2018, when they received the devastating news that nine-year-old daughter Abby had life-threatening leukemia, they tried to focus on finding a way out of the situation.
She had great doctors and a precise, effective treatment regimen; her outlook was positive.
Until that is, the hospital ran out of the drugs that were keeping her alive.
Abby’s mother Laura, from Florida, was shocked when, one afternoon
Households across Britain face a second winter of sky-high energy bills due to a lack of gas storage facilities to prevent supply shortages.
Days after British Gas owner Centrica announced record profits of £969million, energy experts have warned the UK’s continued dependence on imports will put us at the mercy of wholesale price fluctuations.
They argue the Government has failed to ensure the country is fully prepared for a cold winter when increased demand for gas and electricity will bring
Second-quarter profits rose for mirror supplier Gentex Corp. as a result of improved light-vehicle production and fewer supply chain disruptions.
The Zeeland, Mich., company said in a call with investors Friday that net income climbed 51 percent to $109.2 million. The surge is partially magnified by the decrease in profits Gentex experienced in the second quarter of 2022 as a result of component shortages.
“Last year, when we started launching with customers like Hyundai, there was a direction and a
Experts today slammed the US Government for failing to stock up on key flu drugs and antibiotics during the pandemic — despite warnings that a whirlwind of seasonal illness would return with a vengeance post-lockdown.
America is running out of five essential medicines, including the frontline child antibiotic amoxicillin and Tamiflu, as a wave of flu, respiratory syncytial virus (RSV) and other cold viruses overwhelm pediatric hospitals.
Covid lockdowns, mask mandates and the virus itself sidelined most seasonal infections for
Britain’s current drug shortages are partly being fuelled by EU red tape that blocks pharmacies from sharing in-stock medicines.
Industry bodies want No10 to ditch the rule so they can trade medications and help end the ‘postcode lottery’ for HRT, blood pressure drugs, antibiotics, and dozens of other medications plagued by supply issues, MailOnline can reveal.
Pharmacies were once allowed to sell up to 5 per cent of their stock to other stores without needing a special licence that costs
